Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

F David Hale

Affiliations

  • Director at Oncternal Therapeutics Inc. (ONCT), 2019-09-16
  • Director at Conatus Pharmaceuticals Inc. (CNAT), 2019-07-01
  • Director at Biocept Inc (BIOC), 2019-06-19
  • Director at Santarus Inc (SNTS), 2014-01-06
  • Director at Pernix Sleep Inc. (SOMX), 2013-03-08
  • Director at Micromet Inc. (MITI), 2012-03-10
Insider Trading: Purchases See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
BIOC $1.10 90,909 Director 109,099 2016-10-19 Filing
BIOC $1.00 50,000 Director 138,356 2016-05-04 Filing
BIOC $1.25 40,000 Officer, Director 94,570 2015-02-13 Filing
CNAT $11.00 2,588 Director 143,739 2013-07-30 Filing
SNTS $5.34 2,000 Director 18,000 2012-03-21 Filing
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
SOMX $2.68 107,893 Director 360,187 2010-12-01 Filing
MITI $7.24 30,000 Director, Other 108,786 2010-06-16 Filing
MITI $4.66 2,000 Director 152,046 2009-06-10 Filing
MITI $4.66 2,000 Director 154,046 2009-06-10 Filing
MITI $4.66 50,000 Director 156,046 2009-06-10 Filing